Ajanta Pharma (India) Investor Sentiment

AJANTPHARM   2,586  21.20  0.83%   
Under 63% of Ajanta Pharma's investor base is looking to short. The analysis of overall sentiment of trading Ajanta Pharma Limited stock suggests that many investors are alarmed at this time. Ajanta Pharma's investing sentiment shows overall attitude of investors towards Ajanta Pharma Limited.
  
over a year ago at news.google.com         
Ajanta Pharmas growth levers are in place 4 reasons it is this weeks stock pick - Economic Times
Google News at Macroaxis
over a year ago at news.google.com         
Global Cilnidipine Market 2023 Dynamics, Size, Share ... - Cottonwood Holladay Journal
Google News at Macroaxis
over a year ago at news.google.com         
Indian Pharma Market Sales Decline First Time In 11 Months - BQ Prime
Google News at Macroaxis
over a year ago at news.google.com         
Ajanta Pharma Q4 Results Review - Margins Impacted By Lower Branded Market Sales Systematix - BQ Pri...
Google News at Macroaxis
over a year ago at news.google.com         
Coal India share price tanks 3 percent after Q4 net profit falls nearly 18 Should you buy, sell or h...
Google News at Macroaxis
over a year ago at news.google.com         
Ajanta pharma Ltd reports lower consolidated PAT of Rs. 122.25 ... - Equity Bulls
Google News at Macroaxis
over a year ago at news.google.com         
Top News Today, 5 May 2023 Manipur Violence, KL Rahuls Injury Update, Indo-Chinese Talks In Goa, Baj...
Google News at Macroaxis
over a year ago at news.google.com         
On a path to recovery 5 midcap pharma stocks with an upside potential up to 32 percent - The Economi...
Google News at Macroaxis
over a year ago at news.google.com         
Sun Pharma To See Supply Issues From Mohali Plant After FDA Directives - BQ Prime
Google News at Macroaxis
over a year ago at news.google.com         
Defence Stocks 9 Premier Explosives Strong Value or Value Trap - Moneylife
Google News at Macroaxis
over a year ago at news.google.com         
Ajanta Pharma stock performs better than its underlying earnings growth over last three years - Simp...
Google News at Macroaxis
over a year ago at news.google.com         
Ajanta Pharma Steady Growth, Reasonable Valuation - Moneylife
Google News at Macroaxis
over a year ago at news.google.com         
Ajanta Pharma share buyback record date set for today. Key details in 5 points Mint - Mint
Google News at Macroaxis
over a year ago at news.google.com         
Owning 54 percent in Ajanta Pharma Limited means that insiders are heavily invested in the companys ...
Google News at Macroaxis
over a year ago at news.google.com         
Top Broking Houses Placed Buy On 2 Midcap Pharma Stocks, Shares Can Surge Upto 24 percent - Goodretu...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ajanta Pharma that are available to investors today. That information is available publicly through Ajanta media outlets and privately through word of mouth or via Ajanta internal channels. However, regardless of the origin, that massive amount of Ajanta data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ajanta Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ajanta Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ajanta Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ajanta Pharma alpha.

Ajanta Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Stock market update Nifty Pharma index 0.44 percent - MSN
12/16/2024
2
Ajanta Pharma Stock Gains 3.3 percent to Reach Rs 3,018.55 on January 7, 2025 - MarketsMojo
01/06/2025
3
Stock Market Live GIFT Nifty Near 23,400 Ajanta Pharma, Biocon, Container Corp Share Prices In Focus - NDTV Profit
01/30/2025
4
What Ajanta Pharma Limiteds PE Is Not Telling You - Simply Wall St
02/19/2025

Complementary Tools for Ajanta Stock analysis

When running Ajanta Pharma's price analysis, check to measure Ajanta Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ajanta Pharma is operating at the current time. Most of Ajanta Pharma's value examination focuses on studying past and present price action to predict the probability of Ajanta Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ajanta Pharma's price. Additionally, you may evaluate how the addition of Ajanta Pharma to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum